358 related articles for article (PubMed ID: 29031580)
1. Prevalence and characteristics of coronary artery disease in heart failure with preserved and mid-range ejection fractions: A systematic angiography approach.
Trevisan L; Cautela J; Resseguier N; Laine M; Arques S; Pinto J; Orabona M; Barraud J; Peyrol M; Paganelli F; Bonello L; Thuny F
Arch Cardiovasc Dis; 2018 Feb; 111(2):109-118. PubMed ID: 29031580
[TBL] [Abstract][Full Text] [Related]
2. Implications of coronary artery disease in heart failure with preserved ejection fraction.
Hwang SJ; Melenovsky V; Borlaug BA
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2817-27. PubMed ID: 24768876
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: Single-centre experience and comprehensive meta-analysis.
Manchuelle A; Pontana F; De Groote P; Lebert P; Fertin M; Baijot M; Hurt C; Lamblin N; Debry N; Schurtz G; Pentiah AD; Sudre A; Remy-Jardin M; Lancellotti P; Van Belle E; Bauters C; Lemesle G; Delhaye C
Arch Cardiovasc Dis; 2018 Nov; 111(11):686-701. PubMed ID: 29861294
[TBL] [Abstract][Full Text] [Related]
4. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
5. Detection of significant coronary artery disease by noninvasive anatomical and functional imaging.
Neglia D; Rovai D; Caselli C; Pietila M; Teresinska A; Aguadé-Bruix S; Pizzi MN; Todiere G; Gimelli A; Schroeder S; Drosch T; Poddighe R; Casolo G; Anagnostopoulos C; Pugliese F; Rouzet F; Le Guludec D; Cappelli F; Valente S; Gensini GF; Zawaideh C; Capitanio S; Sambuceti G; Marsico F; Perrone Filardi P; Fernández-Golfín C; Rincón LM; Graner FP; de Graaf MA; Fiechter M; Stehli J; Gaemperli O; Reyes E; Nkomo S; Mäki M; Lorenzoni V; Turchetti G; Carpeggiani C; Marinelli M; Puzzuoli S; Mangione M; Marcheschi P; Mariani F; Giannessi D; Nekolla S; Lombardi M; Sicari R; Scholte AJ; Zamorano JL; Kaufmann PA; Underwood SR; Knuuti J;
Circ Cardiovasc Imaging; 2015 Mar; 8(3):. PubMed ID: 25711274
[TBL] [Abstract][Full Text] [Related]
6. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study.
Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
Arch Cardiovasc Dis; 2014 Feb; 107(2):112-21. PubMed ID: 24388161
[TBL] [Abstract][Full Text] [Related]
7. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status - Report From the Japanese Nationwide Multicenter Registry.
Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.
Sun LY; Tu JV; Bader Eddeen A; Liu PP
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909401
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Significant Coronary Artery Disease in Patients with Cerebral Artery Atherosclerosis.
Roh JW; Kwon BJ; Ihm SH; Lim S; Park CS; Chang K; Chung WS; Kim DB; Kim SR; Kim HY
Cerebrovasc Dis; 2019; 48(3-6):226-235. PubMed ID: 31825937
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction.
Rusinaru D; Houpe D; Szymanski C; Lévy F; Maréchaux S; Tribouilloy C
Eur J Heart Fail; 2014 Sep; 16(9):967-76. PubMed ID: 25111982
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of coronary CT angiography in heart failure patients with preserved ejection fraction.
Yu MM; Zuo WX; Zhao X; Tang XL; Chen YY; Dong LL; Shu XH; Jin H; Zeng MS
Eur Radiol; 2023 May; 33(5):3052-3063. PubMed ID: 36629927
[TBL] [Abstract][Full Text] [Related]
13. [Pathological characteristics of the heart and coronary artery from elderly heart failure patients with preserved ejection fraction and coronary artery disease].
Chai K; Wang H; Li YY; Luo Y; Fang F; Liu DG; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Aug; 45(8):710-715. PubMed ID: 28851190
[No Abstract] [Full Text] [Related]
14. Importance of Nonobstructive Coronary Artery Disease in the Prognosis of Patients With Heart Failure.
Braga JR; Austin PC; Ross HJ; Tu JV; Lee DS
JACC Heart Fail; 2019 Jun; 7(6):493-501. PubMed ID: 31078476
[TBL] [Abstract][Full Text] [Related]
15. Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.
Buszman PE; Buszman PP; Banasiewicz-Szkróbka I; Milewski KP; Żurakowski A; Orlik B; Konkolewska M; Trela B; Janas A; Martin JL; Kiesz RS; Bochenek A
JACC Cardiovasc Interv; 2016 Feb; 9(4):318-327. PubMed ID: 26892080
[TBL] [Abstract][Full Text] [Related]
16. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.
Taqueti VR; Hachamovitch R; Murthy VL; Naya M; Foster CR; Hainer J; Dorbala S; Blankstein R; Di Carli MF
Circulation; 2015 Jan; 131(1):19-27. PubMed ID: 25400060
[TBL] [Abstract][Full Text] [Related]
17. Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study.
John JE; Claggett B; Skali H; Solomon SD; Cunningham JW; Matsushita K; Konety SH; Kitzman DW; Mosley TH; Clark D; Chang PP; Shah AM
J Am Heart Assoc; 2022 Sep; 11(17):e021660. PubMed ID: 36000416
[TBL] [Abstract][Full Text] [Related]
18. Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease.
Nardin M; Verdoia M; Negro F; Rolla R; Tonon F; De Luca G
Eur J Clin Invest; 2020 Feb; 50(2):e13181. PubMed ID: 31659742
[TBL] [Abstract][Full Text] [Related]
19. Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation.
Freixa X; Chan J; Bonan R; Ibrahim R; Lamarche Y; Demers P; Basmadjian A; Ibrahim R; Cartier R; Asgar AW
Catheter Cardiovasc Interv; 2015 Feb; 85(3):450-8. PubMed ID: 25115215
[TBL] [Abstract][Full Text] [Related]
20. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice.
Van Mieghem NM; van der Boon RM; Faqiri E; Diletti R; Schultz C; van Geuns RJ; Serruys PW; Kappetein AP; van Domburg RT; de Jaegere PP
JACC Cardiovasc Interv; 2013 Aug; 6(8):867-75. PubMed ID: 23871511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]